Theranos
closedBlood testing and early disease detection services.
Launch date
–
Employees
Market cap
-
Enterprise valuation
€1 (Public information from Sep 2018)
Palo Alto California (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
$9.1m | Series B | ||
$28.5m | Series C | ||
N/A | $45.0m | Late VC | |
$50.0m | Late VC | ||
N/A | $199m | Growth Equity VC | |
N/A | N/A Valuation: $9.0b | Late VC | |
$349m | Growth Equity VC | ||
$582m | Secondary | ||
* |
| $100m | Debt |
* | N/A | N/A | Bankruptcy |
Total Funding | €624m |
Related Content
Recent News about Theranos
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.